FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

11236211000001107: Prezista 300mg tablets (Janssen-Cilag Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40398101000001114 Prezista 300mg tablets (Janssen-Cilag Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
40398201000001119 Prezista 300mg tablets (Janssen-Cilag Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prezista 300mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) Is a Darunavir 300mg tablets true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) Is a Darunavir 300mg tablets false Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) Has active ingredient Darunavir ethanolate false Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) Is a Product containing precisely darunavir 300 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) Has active ingredient Darunavir ethanolate false Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) Is a Prezista true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Darunavir true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) Has specific active ingredient Darunavir ethanolate true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) Has active ingredient Darunavir false Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) Has basis of strength substance Darunavir true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Is pack of False Prezista 300mg tablets (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Has AMP True Prezista 300mg tablets (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start